"The FDA often looks to its panels of outside experts for advice about experimental therapies before making approval decisions and usually follows their recommendations."
Funny, how past panels have recommended Genasense for approval then the FDA turns around and denies the NDA.
I hope the FDA feels the pressure this time around. Alot of eyes will be following their forthcoming descisions.
You would think the FDA would loosen up a bit. And let the drugs prove themselves in the market place, and if their is negligence in behalf of companies. Well, let the Tort lawyers clean out send them to live with their moms.
News 
Market Data 
Discover 
